[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632425":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":38,"responsibleParty":74,"collaborators":18,"id":76,"slug":77,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":80,"acronym":18,"eligibilityCriteria":81,"healthyVolunteers":78,"sex":82,"minAge":83,"maxAge":18,"enrollmentInfo":84,"targetDuration":18,"studyType":87,"phases":88,"briefSummary":90,"conditions":91,"keywords":93,"overallStatus":41,"whyStopped":18,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"BioMérieux","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention","EXPERIMENTAL","At the intervention site, subjects meeting the inclusion and exclusion criteria, and who provide consent to participate in the study, will have a respiratory sample tested on the SPOTFIRE R\u002FST Panel, with results used by the treating clinician to guide management . At the end of the visit, enrolled patients will take a satisfaction survey, based on the AHRQ-validated CAHPS survey. Providers at the intervention site will participate in the AMS and implementation science interventions designed in the pre-implementation phase.",[13],"Device: SPOTFIRE R\u002FST Diagnostic Test",{"label":15,"type":16,"description":17,"interventionNames":18},"Control","NO_INTERVENTION","At the control site and at the discretion of the treating clinician, patients will have their respiratory samples tested on the clinic's usual standard of care (SOC) respiratory antigen tests, with results used by the treating clinician to guide management. Patients at the control site who meet inclusion and exclusion criteria and agree to participate will also take the CAHPS-based satisfaction survey.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DEVICE","SPOTFIRE R\u002FST Diagnostic Test","At the intervention site, subjects meeting the inclusion and exclusion criteria, and who provide consent to participate in the study, will have a respiratory sample tested on the SPOTFIRE R\u002FST Panel, with results used by the treating clinician to guide management . At the end of the visit, enrolled patients will take a satisfaction survey, based on the AHRQ-validated CAHPS survey",[9],[26],{"name":27,"affiliation":5,"role":28},"Andrea Prinzi, PhD","PRINCIPAL_INVESTIGATOR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Alyssa Duenes","CONTACT","208-881-2410","alyssa.duenes@biomerieux.com",{"name":27,"role":32,"phone":36,"phoneExt":18,"email":37},"303-646-7446","andrea.prinzi@biomerieux.com",[39,60],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"American Family Care - Gardendale","RECRUITING","Gardendale","Alabama","35071","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-86.81277,33.6601,{"lat":51,"lon":50},[54,58],{"name":55,"role":32,"phone":56,"phoneExt":18,"email":57},"Beverly McKee, PharmD","205-271-5047","bmckee@americanfamilycare.com",{"name":59,"role":28,"phone":18,"phoneExt":18,"email":18},"Jessica Higginbotham, PharmD",{"facility":61,"status":41,"city":62,"state":43,"zip":63,"country":45,"countryCode":46,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"American Family Care - Grove","Hoover","35226",{"type":48,"coordinates":65},[66,67],-86.81138,33.40539,{"lat":67,"lon":66},[70,73],{"name":59,"role":32,"phone":71,"phoneExt":18,"email":72},"205-421-2103","jlhigginbotham@AMERICANFAMILYCARE.com",{"name":59,"role":28,"phone":18,"phoneExt":18,"email":18},{"type":75,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100632425","impact-of-a-multiplex-respiratory-pcr-test-on-outcomes-for-patients-presenting-with-respiratory-illness-in-the-urgent-care-setting-a-hybrid-effectiveness-quasi-experimental-trial-100632425",false,"NCT07513519","Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial","Inclusion Criteria:\n\n* Patients older than 1 year\n* Patients presenting with signs and symptoms of acute respiratory illness including but not limited to bronchitis, bronchiolitis, rhinitis, pharyngitis, tonsillitis, and laryngitis\n* First visit for respiratory indication within the study period\n\nExclusion Criteria:\n\n* Patients younger than 1 year\n* Patients for which there is a clinical suspicion of pneumonia (i.e., severe illness on presentation requiring hospitalization or not eligible for urgent care)\n* Patients experiencing symptoms for \\> 10 days\n* Patients with significant respiratory comorbidities, including COPD, emphysema, pulmonary fibrosis, diseases causing chronic respiratory tract inflammation, and other conditions\n* Patients with other significant oropharyngeal or upper respiratory comorbidities or conditions, including but not limited to nasal deformations, peritonsillar abscess\n* Had a previous visit for respiratory indication within the study period","ALL","1 Year",{"count":85,"type":86},800,"ESTIMATED","INTERVENTIONAL",[89],"NA","This research study will use a hybrid effectiveness-implementation type 1 design to assess effectiveness of the Spotfire R\u002FST assay in the urgent care setting. A hybrid effectiveness-implementation type 1 study primarily focuses on the effectiveness of an intervention (e.g., use of Spotfire R\u002FST) but also simultaneously allows for the collection of data on the barriers and facilitators of implementing the Spotfire R\u002FST test in the real-world urgent care setting.",[92],"Acute Respiratory Infections (ARIs)",[94,95,96,5],"SPOTFIRE","R\u002FST","BioFire","2026-03-30",{"date":99,"type":100},"2026-04-07","ACTUAL",{"date":102,"type":100},"2025-12-22",{"date":104,"type":86},"2026-04",{"name":5,"class":6},2]